Biologics in the Treatment of Spine Disorders and Trauma

The bone graft and bone substitute market has grown at a solid rate since 2000, and, despite current economic restrictions, will continue to grow throughout the forecast period. Some of the drivers of this market include the need to increase fusion rates, growth in spine fusion procedure volumes, an increased number of bone products, and the introduction of growth factors. The aggregate date below represents sales from 2010 to 2020 of allografts, demineralized bone matrix (DBM) and bone morphogenetic proteins (BMPs) in treatment of spine-related disorders and trauma.

Prices are under pressure and declining, but demand is still positive and driving growth.

Source: Worldwide Spine Surgery: Products, Technologies, Markets and Opportunities 2010-2020 (July 2011).

Leave a Reply